We found that repression of CDH2 blocked meningioma tumorigenesis (Fig. 6e), and moreover, that both genetic and pharmacologic inhibition of CDH2 with ADH-1 attenuated meningioma cell proliferation in coculture with human cerebral organoids (Fig. 6f, g). The gene discussed is ADH1A; the disease is meningioma.